Last update 20 Dec 2025

Multiple non-standardized allergenic extracts (ALK-Abello)

Overview

Basic Info

Drug Type
Allergen extract
Synonyms
Allergenic Extracts
Target-
Action
modulators
Mechanism
Immunomodulators
Therapeutic Areas
Immune System Diseases
Active Indication
Anaphylaxis
Inactive Indication-
Originator Organization
ALK-Abello A/SALK-Abello A/S
Active Organization
ALK-Abello A/SALK-Abello A/S
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (27 Feb 2023),
Anaphylaxis
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with Multiple non-standardized allergenic extracts (ALK-Abello)
NCT07195929
/ Not yet recruitingNot Applicable
Blomia Tropicalis Allergen Extract. Determination of the Vivo Histamine Equivalent Prick Test Units
NCT06957496
/ CompletedNot Applicable
Phleum Pratense and Dactylis Glomerata Allergen Extracts. Determination of the in Vivo Histamine Equivalent Prick Test Units
NCT05533385
/ CompletedNot Applicable
Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts. Determination of the in Vivo Allergenic Potency in Histamine Equivalent Units (HEP).
100 Clinical Results associated with Multiple non-standardized allergenic extracts (ALK-Abello)
Login to view more data
100 Translational Medicine associated with Multiple non-standardized allergenic extracts (ALK-Abello)
Login to view more data
100 Patents (Medical) associated with Multiple non-standardized allergenic extracts (ALK-Abello)
Login to view more data
100 Deals associated with Multiple non-standardized allergenic extracts (ALK-Abello)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anaphylaxis
United States
ALK-Abello A/SALK-Abello A/S
27 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free